Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Insulin Injection Aids Market, By Product, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1606459
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 284 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,574,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,544,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,952,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå ±Ô¸ð´Â 2023³â 2¾ï 3,980¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 7.40%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå - ½ÃÀå ¿ªÇÐ

Àü ¼¼°è ´ç´¢º´ À¯º´·ü Áõ°¡·Î ½ÃÀå ¼ö¿ä Áõ°¡

´ç´¢º´ÀÇ Àü ¼¼°è À¯º´·üÀÌ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ±¹Á¦´ç´¢º´¿¬¸ÍÀº 2021³â¿¡´Â ¾à 5¾ï 3,700¸¸ ¸íÀÇ ¼ºÀÎÀÌ ´ç´¢º´À» ¾Î°í ÀÖÀ» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ ¼öÀÇ Áõ°¡´Â Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü Àν¶¸° ÁÖÀÔ º¸Á¶ ±â±âÀÇ Ãʱ⠺ñ¿ëÀÌ È¯Àڵ鿡°Ô °í°¡ÀÏ ¼ö ÀÖ°í, »õ·Î¿î ÀÇ·á±â±âÀÇ ½ÂÀÎ ÀýÂ÷´Â ½Ã°£ÀÌ ¿À·¡ °É¸®°í º¹ÀâÇϱ⠶§¹®¿¡ ¾÷°èÀÇ ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ý´ë·Î ´ç´¢º´ °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå È®´ëÀÇ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½º¸¶Æ® Ææ°ú Àν¶¸° ÆßÇÁ¿Í °°Àº ÷´Ü Àν¶¸° Àü´Þ ÀåÄ¡ÀÇ °³¹ßÀº ´ç´¢º´ °ü¸®¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.

Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¸Å³â ¾à 7.40%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° ¼¼ºÐÈ­¿¡ µû¶ó ÁÖ»ç±â º¸Á¶Á¦´Â 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ ¼¼ºÐÈ­¸¦ ±âÁØÀ¸·Î 2023³â¿¡´Â º´¿øÀÌ ÁÖ¿ä ºÎ¹®ÀÔ´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì Àν¶¸° ÁÖ»ç º¸Á¶±â±¸°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ¸·Î ºÎ»óÇß½À´Ï´Ù.

Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ¼¼°è ½ÃÀåÀº Á¦Ç°, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

Á¦Ç°Àº ÁÖ»ç º¸Á¶±â±¸, Àν¶¸° ¹ÙÀÌ¾Ë º¸Á¶±â±¸, ¾î¸°ÀÌ º¸Á¶±â±¸, ÀÎÁ§ÅÍ, ±âŸ 5°¡Áö·Î ³ª´¹´Ï´Ù. ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ´Â °ÍÀº ÁÖ»ç±â º¸Á¶±â±¸ ºÐ¾ßÀÔ´Ï´Ù. ÀÌ´Â ÁÖ·Î Àú·ÅÇÑ °¡°Ý°ú ÁÖ»ç ¹Ù´Ã À¯µµ ¹× ÀÎü °øÇÐÀû µðÀÚÀΰú °°Àº ¾ÈÀü ±â´ÉÀ¸·Î ÀÎÇØ ÁÖ»ç ½Ã Æí¸®ÇÔ°ú Æí¾ÈÇÔÀ» Çâ»ó½Ã۱⠶§¹®ÀÔ´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó Àü¹® Ŭ¸®´Ð, º´¿ø, º´¿ø, ȨÄɾî ȯ°æ, ±âŸÀÇ 4°¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â º´¿ø ºÐ¾ßÀÔ´Ï´Ù. ÀÌ´Â ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡ÀÇ °¡¿ë¼º°ú Á¤ºÎ ¹× ¹Î°£ ºÎ¹®ÀÇ ÅõÀÚ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. µû¶ó¼­ º¹ÀâÇÑ ´ç´¢º´ ȯÀÚ¸¦ Ä¡·áÇϱâ À§Çؼ­´Â È¿À²ÀûÀÎ Àν¶¸° Àü´Þ ½Ã½ºÅÛÀÌ ÇÊ¿äÇÏ´Ù´Â Á¡ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

Àν¶¸° ÁÖ»ç º¸Á¶Á¦ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¸®ÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á®¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù.

Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå - °æÀï »óȲ:

´ç´¢º´ À¯º´·ü Áõ°¡·Î Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀåÀÇ ±â¼ú Çõ½ÅÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ÀÎü°øÇÐÀû ¼³°è¿Í ÅëÇÕµÈ ¾ÈÀü ¸ÞÄ¿´ÏÁò°ú °°Àº ±â´ÉÀ» ÅëÇØ »ç¿ëÀÚ °æÇèÀ» Çâ»ó½ÃŰ´Â ÷´Ü Àü´Þ ÀåÄ¡ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Àü·«Àû Á¦ÈÞ¿Í Çù·Â °ü°è´Â ½ÃÀå ÁøÃâ È®´ë¿Í ±â¼ú ÅëÇÕÀ» Çâ»ó½ÃŰ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦Á¶»çµéÀº º¸´Ù È¿°úÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀåÄ¡¸¦ °³¹ßÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ±ÔÁ¦ Ç¥ÁØÀ» ÁؼöÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. °æÀïÀÌ Ä¡¿­ÇØÁü¿¡ µû¶ó ¾÷üµéÀº ´Ù¾çÇÑ È¯ÀÚ Áý´ÜÀÇ ¿ä±¸¸¦ ÃæÁ·½ÃŰ¸é¼­ ½ÃÀåÀÇ Àå±âÀûÀÎ ¼ºÀå°ú Áö¼Ó°¡´É¼ºÀ» º¸ÀåÇϱâ À§ÇØ °¡°Ý ¹× Á¢±Ù¼ºÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ »ê¾÷ Á¶»ç

Á¦5Àå Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå »óȲ

Á¦7Àå Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå : Á¦Ç°º°

Á¦8Àå Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦9Àå Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå : Áö¿ªº°

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® - Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ¾÷°è

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Insulin injection aids market size was valued at USD 239.80 Million in 2023, expanding at a CAGR of 7.40% from 2024 to 2032.

Insulin injection aids are medical devices designed to facilitate the administration of insulin for diabetes management. These aids enhance the delivery process by providing features, such as ergonomic designs, needle guidance, and integrated safety mechanisms to prevent needle stick injuries. Common types include insulin pens, syringes, and insulin pumps, which offer various methods of insulin delivery. By improving accuracy, convenience, and comfort, insulin injection aids empower patients to manage their diabetes more effectively.

Insulin Injection Aids Market- Market Dynamics

Increasing prevalence of diabetes worldwide to boost market demand

The global prevalence of diabetes is increasing significantly, with the International Diabetes Federation reporting that approximately 537 million adults are living with diabetes in 2021. This growing patient population creates a higher demand for insulin injection aids market. However, the initial cost of advanced insulin delivery devices can be prohibitive for some patients and the approval process for new medical devices can be lengthy and complex, which may restrict the industry growth. On the contrary, increasing awareness about diabetes management is creating opportunities for market expansion. Furthermore, the development of advanced insulin delivery devices, such as smart pens and insulin pumps, is transforming diabetes management.

Insulin Injection Aids Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.40% over the forecast period (2024-2032)

Based on product segmentation, syringe aids is predicted to show maximum market share in the year 2023

Based on end-use segmentation, hospitals were the leading segment in 2023

On the basis of region, the North America insulin injection aids North America was the leading revenue generator in 2023

Insulin Injection Aids Market- Segmentation Analysis:

The Global Insulin Injection Aids Market is segmented on the basis of Product, End-use, and Region.

The market is divided into five categories based on product: syringe aids, insulin vial aids, aids for aids, injectors, and others. The syringe aids sector dominates the market. This is mainly due to their affordability and safety features, such as needle guidance and ergonomic designs, enhancing convenience and comfort during injections.

The market is divided into four categories based on end-use: specialty clinics, hospitals, home care settings, and others. The hospitals sector is predicted to grow at the highest CAGR during the forecast period. This is partly due to the availability of skilled healthcare professionals and increased investments from both government and private sectors. This emphasizes the need for efficient insulin delivery systems in treating complicated diabetes cases.

Insulin Injection Aids Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Insulin Injection Aids Market- Competitive Landscape:

The rising prevalence of diabetes is driving innovation in the insulin injection aids market. Companies are focusing on developing advanced delivery devices that enhance user experience through features like ergonomic designs and integrated safety mechanisms. Strategic partnerships and collaborations are becoming crucial for expanding market reach and improving technology integration. Furthermore, manufacturers are investing in research and development to create more effective and user-friendly devices, ensuring compliance with regulatory standards. As competition intensifies, companies are also prioritizing affordability and accessibility, aiming to meet the needs of diverse patient populations while ensuring long-term growth and sustainability in the market.

Recent Developments:

In August 2024, Abbott partnered with Medtronic to create an integrated continuous glucose monitoring (CGM) system using Abbott's advanced FreeStyle Libre technology. This collaboration will connect with Medtronic's automated insulin delivery systems, allowing automatic insulin adjustments to maintain glucose levels, enhancing diabetes management for patients.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INSULIN INJECTION AIDS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL INSULIN INJECTION AIDS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

GLOBAL INSULIN INJECTION AIDS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

GLOBAL INSULIN INJECTION AIDS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Insulin Injection Aids Market Overview

2. Executive Summary

3. Insulin Injection Aids Key Market Trends

4. Insulin Injection Aids Industry Study

5. Insulin Injection Aids Market: Impact of Escalating Geopolitical Tensions

6. Insulin Injection Aids Market Landscape

7. Insulin Injection Aids Market - By Product

8. Insulin Injection Aids Market - By End-use

9. Insulin Injection Aids Market- By Geography

10. Key Vendor Analysis- Insulin Injection Aids Industry

11. 360 Degree Analyst View

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â